BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Early pregnancy factor
,
Doxorubicin
,
rs7903146
,
CXCL2
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
adenosine receptor antagonist
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Genomics Assisted Toxicity Evaluation system study - Rat Hepatocytes
Explore Curated Studies Results
Literature
Most Relevant Literature
Quantitative structure-activity relationship study on affinity profile of a series of 1,8-naphthyrid…
Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine recep…
Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine recep…
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine rece…
Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitaliz…
PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitaliz…
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility…
A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ